August 25

AMSTERDAM, The Netherlands, August 25, 2011 - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

LONDON, August 25, 2011 - Fizzback is proud to announce it has been selected by Virgin Media to enhance their customers' experience and drive performance improvement across their call centres.

DUBAI, UAE, August 25, 2011 - The Ministry of Labour's recent efforts to tackle Saudi's high unemployment rate which has hit half a million poses a major threat to a large number of Saudi organizations, a fifth of which stands in the danger of being classified under the red zone.

PARIS, August 25, 2011 - -Performance Reflecting Business Model's Robustness and First Effects of the Strategy Implementation, After One Year as a Standalone Company Robust like-for-like performance in first-half 2011 Issue volume up 10.0% to €7,264 million EBIT up 12.1% to €167 million Recurring profit after tax up 31.3%[1] to €96 million Funds from operations[2] (FFO) up 20.2% to €119 million Results that reflect the Group's long-term strategy, focused on: Issue volume organic growth in the core business Objective confirmed: normalized growth in issue volume of between 6% and 14% per year like-for-like Accelerating the digital transition Objective confirmed: paperless solutions to account for 50% of issue volume by 2012 Full-year 2011 EBIT target: €340 million to €360 million The consolidated financial statements for the six months ended June 30, 2011 were approved by the Board of Directors on August 24, 2011.
Older News
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2011 The Gaea Times